Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12.8M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
1.07M
-
Shares change
-
-96.4K
-
Total reported value, excl. options
-
$1.43M
-
Value change
-
-$128K
-
Number of sells
-
-7
-
Price
-
$1.33
Significant Holders of Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) as of Q3 2024
11 filings reported holding BFRI - Biofrontera Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07M shares
of 12.8M outstanding shares and own 8.4% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (501K shares), Rosalind Advisors, Inc. (495K shares), SCOTIA CAPITAL INC. (50K shares), GEODE CAPITAL MANAGEMENT, LLC (17.1K shares), BlackRock, Inc. (4.62K shares), UBS Group AG (3.1K shares), OSAIC HOLDINGS, INC. (576 shares), Tower Research Capital LLC (TRC) (276 shares), BANK OF AMERICA CORP /DE/ (24 shares), and WELLS FARGO & COMPANY/MN (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.